AllergologyNews.net

Allergology Xagena

Xagena Mappa
Medical Meeting
Mediexplorer.it
XagenaNewsletter

Search results for "Omalizumab"

Data from seven clinical studies demonstrate that in patients with severe allergic asthma who require treatment with oral corticosteroids – indicating that they have a more severe form of the disease ...


Long-term data show that Xolair ( Omalizumab ), a first-in-class monoclonal antibody for treating severe allergic asthma, helped patients to maintain control of their disease and was safe and well-tol ...


European Commission has granted marketing authorization in all 25 EU member states for the novel asthma therapy Xolair ( Omalizumab ). Xolair offers a unique therapeutic approach by blocking the ac ...


A new study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford has shown that an asthma drug accelerates the process of desensitizing patient ...